Profile
Iron Path Capital is a private equity firm based in Nashville, Tennessee, founded in 2021 by Scott Mraz and Rob Reistetter. Both founders have extensive backgrounds in finance and investment, having studied together at Ithaca College and worked at Quad-C. The firm is known for its operational resources through the Full Immersion Operations team, which supports growth in specialized and technical companies within highly regulated end markets.
The firm primarily invests in the healthcare and specialty industrial sectors, focusing on companies in the United States. Iron Path Capital typically engages in buyout and growth/expansion investments. The firm manages significant assets, including Iron Path Capital Fund II with $450 million in assets under management.
Notable investments by Iron Path Capital include Prolytix - BPO/Outsource Services, Pro-Set Formulated Resin Systems - Specialty Chemicals, American Dermatopathology Laboratory - Laboratory Services, Nalas - Construction and Engineering, and Immuno Spot - Monitoring Equipment.
Industry
Iron Path Capital Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Iron Path Capital Fund II
|
Private Equity (PE)
|
Business Services (B2B)
Chemicals
|
Late Stage (Series C+)
|
North America
|
$10-50 m
|
$450 M
|
October 2026
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.